What's new

Orphan designation: Clofutriben Treatment of Cushing's syndrome of endogenous origin, 16/01/2025 Positive

Orphan designation: Clofutriben Treatment of Cushing's syndrome of endogenous origin, 16/01/2025 Positive

Feb 20, 2025 - 15:18
 0
Orphan designation: Clofutriben Treatment of Cushing's syndrome of endogenous origin, 16/01/2025 Positive
Orphan designation: Clofutriben Treatment of Cushing's syndrome of endogenous origin, 16/01/2025 Positive
Read More

Tags:

Previous Article

The U.S. could face a national hospital bed shortage

Next Article

New Look to exit Republic of Ireland with 347 jobs axed

Related Posts

Summary of opinion: Abrysvo, 27/02/2025 Positive

Summary of opinion: Abrysvo, 27/02/2025 Positive

Feb 28, 2025  0

Training on human variations web-based electronic application form (eAF) functionalities for non-CAPs variations, Online, European Medicines Agency, Amsterdam, the Netherlands, from 11 February 2025, 10:30 (CET) to 11 February 2025, 12:30 (CET)

Training on human variations web-based electronic appli...

Feb 9, 2025  0

Human medicines European public assessment report (EPAR): Trimbow, beclometasone,formoterol,glycopyrronium bromide, Date of authorisation: 17/07/2017, Revision: 9, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 17, 2025  0